Riskpilot← Back to searchSign inGet full accessAndreas Lundholm Vårdkonsult AB
ABActiveOrg 5592085137Lomvägen 583General medical practice activities · NACE 8621Est. 20190 employees
Revenue 2025
SEK 240K
+47% vs 2024
EBITDA margin
92.2%
+144% vs 2024
Equity ratio
78.7%
Financial strength
Net profit 2025
SEK 177K
+55% vs 2024
| Revenue | SEK 240K | +47% |
| EBITDA | SEK 221K | +144% |
| Net profit | SEK 177K | +55% |
| Total assets | SEK 530K | +29% |
| Equity | SEK 417K | +25% |
| Employees | 0 | — |
Legal name
Andreas Lundholm Vårdkonsult AB
Org number
5592085137
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
10 juni 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva läkarverksamhet prehospitalt och på sjukhus, medicinska konsultuppdrag, utbildning, medicinsk teknisk utveckling och innovation. Vidare ska bolagets verksamhet även omfatta försäljning av tjänster och produkter inom medicinsk teknik, bedriva event och reklamproduktion, äga och förvalta värdepapper samt därmed förenlig verksamhet.
Address
Lomvägen 583
Email
info@heliosconsulting.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 485 | 229 | 255 | 163 | 240 |
| Staff expenses | — | −170 | −39 | −6 | −0 |
| EBITDA | 196 | −18 | 116 | 91 | 221 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 196 | −18 | 116 | 91 | 221 |
| Net financials | 7 | −6 | 44 | 45 | 2 |
| Profit before tax | 153 | 1 | 271 | 136 | 223 |
| Tax | −34 | −0 | −48 | −22 | −46 |
| Net profit | 119 | 1 | 223 | 114 | 177 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 597 | 409 | 560 | 412 | 530 |
| Equity | 217 | 217 | 440 | 334 | 417 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 245 | 82 | 120 | 77 | 113 |
| Total debt | 245 | 82 | 120 | 77 | 113 |
EBITDA margin
92.2%
This company
15.8%
Market median
+484% vs market
20212025
Equity ratio
78.7%
This company
38.2%
Market median
+106% vs market
20212025
Return on equity
42.6%
This company
18.4%
Market median
+132% vs market
20212025
Net profit margin
73.9%
This company
8.1%
Market median
+812% vs market
20212025
Asset turnover
0.45×
This company
1.12×
Market median
-60% vs market
20212025
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-12-01 – 2025-11-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-11-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Andreas Lundholm Vårdkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Josefine Marie Preetzmann Marqvard | Deputy Board Member | 0 companies |
| Ulf Andreas Lundholm | Board of Directors | 0 companies |